Literature DB >> 9205520

A higher prevalence of onychomycosis in psoriatics compared with non-psoriatics: a multicentre study.

A K Gupta1, C W Lynde, H C Jain, R G Sibbald, B E Elewski, C R Daniel, G N Watteel, R C Summerbell.   

Abstract

There is some controversy about the prevalence of onychomycosis in patients with psoriasis compared to non-psoriatics. We therefore measured the prevalence of toenail onychomycosis in psoriatics and non-psoriatics attending dermatologists' offices. None of the patients had a referring diagnosis of onychomycosis. The prevalence of pedal onychomycosis in psoriatics (n = 561) was 13%. The odds of patients with psoriasis having onychomycosis was 56% greater than non-psoriatics of the same age and sex (P = 0.02). In the psoriatics, when the toenails were clinically abnormal, the prevalence of onychomycosis was 27%. The odds of developing onychomycosis increased with age (P < 0.0001) and the odds of men developing onychomycosis was 2.5 times that of women (P = 0.0001). The duration of psoriasis did not significantly affect the odds of developing onychomycosis. The fungal organisms recovered from psoriasis subjects with onychomycosis were similar to those in the normal population with onychomycosis (P = 0.58).

Entities:  

Mesh:

Year:  1997        PMID: 9205520

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  18 in total

Review 1.  A risk-benefit assessment of the newer oral antifungal agents used to treat onychomycosis.

Authors:  A K Gupta; N H Shear
Journal:  Drug Saf       Date:  2000-01       Impact factor: 5.606

Review 2.  Onychomycosis: modern diagnostic and treatment approaches.

Authors:  Georgi Tchernev; Plamen Kolev Penev; Pietro Nenoff; Liliya Georgieva Zisova; José Carlos Cardoso; Teodora Taneva; Gabriele Ginter-Hanselmayer; Julian Ananiev; Maya Gulubova; Reni Hristova; Desislava Nocheva; Claudio Guarneri; G Martino; Nobuo Kanazawa
Journal:  Wien Med Wochenschr       Date:  2012-09-30

3.  [Fungal nail infections--an update: Part 1--Prevalence, epidemiology, predisposing conditions, and differential diagnosis].

Authors:  P Nenoff; G Ginter-Hanselmayer; H-J Tietz
Journal:  Hautarzt       Date:  2012-01       Impact factor: 0.751

4.  Role of HLA-DR Alleles to Increase Genetic Susceptibility to Onychomycosis in Nail Psoriasis.

Authors:  Hilda Carrillo-Meléndrez; Esteban Ortega-Hernández; Julio Granados; Sara Arroyo; Rodrigo Barquera; Roberto Arenas
Journal:  Skin Appendage Disord       Date:  2016-05-13

5.  Nail changes and nail disorders in the elderly.

Authors:  Sudhakar Rao; Sabyasachi Banerjee; Sadhan Kumar Ghosh; Dwijendra Nath Gangopadhyay; Sukumar Jana; Kakali Mridha
Journal:  Indian J Dermatol       Date:  2010 Jul-Sep       Impact factor: 1.494

6.  A preformulation strategy for the selection of penetration enhancers for a transungual formulation.

Authors:  Biji Palliyil; David B Lebo; Pankil R Patel
Journal:  AAPS PharmSciTech       Date:  2013-04-10       Impact factor: 3.246

7.  Study of nail changes and nail disorders in the elderly.

Authors:  Sudhakar Rao; Sabyasachi Banerjee; Sadhan Kumar Ghosh; Dwijendra Nath Gangopadhyay; Sukumar Jana; Kakali Mridha
Journal:  Indian J Dermatol       Date:  2011 Sep-Oct       Impact factor: 1.494

8.  Nail psoriasis as a severity indicator: results from the PsoReal study.

Authors:  Marc A Radtke; Anna K Langenbruch; Ines Schäfer; Katharina Herberger; Kristian Reich; Matthias Augustin
Journal:  Patient Relat Outcome Meas       Date:  2010-12-22

9.  Treatment of nail psoriasis: common concepts and new trends.

Authors:  Yasemin Oram; A Deniz Akkaya
Journal:  Dermatol Res Pract       Date:  2013-05-13

10.  Onychomycosis due to rhizomucor in psoriatic patient with HIV infection.

Authors:  Ravinder Kaur; Monika Matlani
Journal:  Indian J Dermatol       Date:  2013-05       Impact factor: 1.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.